Executive Summary The purpose of this visiongain report is to examine the prospects of the world gastrointestinal market. The gastrointestinal (GI) disorders market is one of the largest and most important in the pharmaceutical industry, generating revenues of over $16 billion in 2004. This report examines the GI market critically through a comprehensive review of available information, including that from commercial databases, consultation with the industry, company reports, business/industry news and consultation with international experts on GI disorders. Visiongain applied techniques such as financial forecasting, SWOT analysis and the assessment of unmet needs to provide a comprehensive market report with detailed analyses and informed opinion. In particular, this report concentrates on the following essential aspects of the GI market: - The current state of the world market for drugs to treat gastrointestinal disorders
- Drivers and opportunities in the GI market
- Restraints and threats in the GI market
- Revenue trends in the world gastrointestinal market between 2005-2011
- Prospects for the leading GI drugs between 2005-2011
- A comprehensive discussion of patent expiry and generic substitution
- An assessment of prescription-to-OTC switching and lifecycle management
- A breakdown of the world GI market into the principal geographical regions, with estimates of potential treatment populations and forecasted revenues to 2011
- An analysis of unmet needs in the GI market, with discussion of potential solutions
- A discussion of pricing, with comparisons between leading products and substitutes
- A discussion of DTC advertising with emphasis on issues and strategies
- Detailed information on pipeline products, with an analysis of the prospects for these agents
Why you should buy this report - To receive a comprehensive analysis of the prospects of the world gastrointestinal market from 2005-2011
- To find out predicted revenues, growth rates and market shares for all the leading GI drugs from 2005-2011
- To determine the forces that influence the gastrointestinal market, especially:
- Competitive characteristics
- Drivers and restraints
- Strengths, weaknesses, opportunities and threats
- Unmet needs according to world experts, with gaps in the market exposed - To find out the prospects for GI drugs in the leading geographical markets:
- Potential treatment populations
- Potential 2011 revenues in the leading 7 markets - To find out about pipeline developments for treating GI disorders
Table of Contents Download TOC for the report The World Gastrointestinal Disorders Market 2006-2011 in PDF
|
